Last quarter (Q4 2023), Avadel Pharmaceuticals's total revenue was $19.45M, an increase of 16669.83% from the same quarter last year. In Q4, Avadel Pharmaceuticals's net income was $-28.79M. See Avadel Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Total Revenue	$ 27.96M	$ 27.96M	$ 116.00K	-	$ 22.33M	$ 59.22M
Cost of Revenue	$ 846.00K	$ 846.00K	$ -3.35M	-	$ 5.74M	$ 12.13M
Gross Profit	$ 27.12M	$ 27.12M	$ 3.46M	$ 53.00K	$ 16.59M	$ 47.09M
Operating Expense	$ 164.97M	$ 164.97M	$ 95.22M	$ 85.60M	$ 53.25M	$ 63.92M
Operating Income	$ -137.85M	$ -137.85M	$ -98.56M	$ -85.55M	$ -36.66M	$ -16.83M
Net Non Operating Interest Income Expense	$ -9.07M	$ -9.89M	$ -12.34M	$ -7.82M	$ -12.99M	$ -12.48M
Other Income Expense	$ 13.86M	$ 13.04M	$ 536.00K	$ -217.00K	$ 44.57M	$ -9.27M
Pretax Income	$ -160.78M	$ -160.78M	$ -111.44M	$ -93.14M	$ -5.08M	$ -38.58M
Tax Provision	$ -501.00K	$ -501.00K	$ 26.02M	$ -15.82M	$ -12.11M	$ -5.36M
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ -160.28M	$ -160.28M	$ -130.77M	$ -77.33M	$ 7.03M	$ -33.23M
Basic EPS	$ -2.04	$ -2.00	$ -2.29	$ -1.32	$ 0.13	$ -0.89
Diluted EPS	$ -2.04	$ -2.00	$ -2.29	$ -1.32	$ 0.13	$ -0.89
Basic Average Shares	$ 320.70M	$ 80.17M	$ 60.09M	$ 58.53M	$ 53.00M	$ 37.40M
Diluted Average Shares	$ 320.70M	$ 80.17M	$ 60.09M	$ 58.53M	$ 54.94M	$ 37.40M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 165.81M	$ 165.81M	$ 98.56M	$ 85.60M	$ 58.99M	$ 76.04M
Net Income From Continuing And Discontinued Operation	$ -160.28M	$ -160.28M	$ -137.46M	$ -77.33M	$ 7.03M	$ -33.23M
Normalized Income	$ -108.40M	$ -161.28M	-	-	$ -23.05M	$ -25.24M
Interest Expense	-	-	-	-	$ 12.99M	$ 12.48M
EBIT	$ -150.89M	$ -150.89M	$ -99.10M	$ -83.20M	$ 7.91M	$ -26.10M
EBITDA	$ -146.33M	$ -146.33M	$ -91.55M	$ -81.14M	$ 9.60M	$ -23.61M

Currency in USD

Avadel Pharmaceuticals Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing